Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis
ConclusionsOur results suggest that immune tolerance to AHC protein by oral administration is able to provide efficient atheroprotection up to 18 weeks and moderately at later stages. Apart from immune regulatory cells, protective antibodies may also have a role in controlling atherosclerosis.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Chlamydia | Diets | Heart | High Fat | Nutrition | Pneumonia | Study | Toxicology